Ophthalmic Devices - Israel

  • Israel
  • The Ophthalmic Devices market market in Israel is expected to achieve a revenue of US$226.40m in 2024.
  • This market is projected to experience a steady annual growth rate (CAGR 2024-2029) of 6.13%, leading to a market volume of US$304.80m by 2029.
  • It is worth noting that in terms of global comparison, the United States is anticipated to generate the highest revenue in this market, with an estimated revenue of US$14,000.00m in 2024.
  • Israel's booming medical technology sector has made it a hub for innovation in ophthalmic devices, attracting global investment and fostering cutting-edge research.

Key regions: Germany, Italy, France, Japan, United Kingdom

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Ophthalmic Devices market in Israel is experiencing significant growth and development due to various factors. Customer preferences in the Ophthalmic Devices market in Israel are largely influenced by the global trends and advancements in technology. Customers in Israel, like in many other countries, are increasingly seeking innovative and high-quality ophthalmic devices that can provide accurate diagnoses and effective treatments for eye conditions. They are particularly interested in devices that offer non-invasive procedures, minimal discomfort, and quick recovery times. Additionally, customers in Israel prioritize devices that are user-friendly and can be easily integrated into their existing healthcare systems. One of the key trends in the Ophthalmic Devices market in Israel is the growing demand for laser-based devices. Laser technology has revolutionized the field of ophthalmology by offering precise and effective treatments for various eye conditions. In Israel, there is a high adoption rate of laser-based devices for procedures such as LASIK surgery, which corrects vision problems. The increasing popularity of laser-based devices can be attributed to their ability to provide quick and accurate results, minimal pain, and faster recovery times compared to traditional surgical methods. Another trend in the market is the rising demand for diagnostic devices. With the growing awareness about eye health and the importance of early detection and prevention of eye diseases, there is an increasing need for advanced diagnostic devices in Israel. These devices enable healthcare professionals to accurately diagnose eye conditions and provide appropriate treatments. Diagnostic devices such as optical coherence tomography (OCT) scanners and retinal cameras are in high demand in Israel due to their ability to provide detailed and precise images of the eye. Local special circumstances in Israel also contribute to the development of the Ophthalmic Devices market. Israel has a well-developed healthcare system with a strong emphasis on research and innovation. The country is home to several leading ophthalmic device manufacturers and research institutions, which drive the development of new and advanced devices. The government of Israel also provides support and incentives for the development and adoption of innovative medical technologies, including ophthalmic devices. These factors create a favorable environment for the growth of the Ophthalmic Devices market in Israel. Underlying macroeconomic factors, such as the increasing healthcare expenditure and the aging population in Israel, also play a significant role in the development of the Ophthalmic Devices market. As the population ages, the prevalence of eye diseases and conditions increases, leading to a higher demand for ophthalmic devices. The government's focus on improving healthcare infrastructure and increasing access to healthcare services further fuels the demand for ophthalmic devices in Israel. In conclusion, the Ophthalmic Devices market in Israel is experiencing growth and development driven by customer preferences for innovative and high-quality devices, trends such as the adoption of laser-based devices and diagnostic devices, local special circumstances including a strong healthcare system and government support, and underlying macroeconomic factors such as increasing healthcare expenditure and an aging population.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)